APOC3 and cardiovascular disorder: Because loss-of-function mutations in ApoC3 are characterized by a strong decrease in serum triglycerides and decreased cardiovascular risk, ApoC3 has been suggested to be a potent therapeutic approach to control dyslipidemia and cardiovascular disease [11].